CASLOT


Brand:
CASLOT

Manufacturer:
RANBAXY

  
Compositions:
Carvedilol 3.125mg/6.25mg/12.5mg/25mg tablets,
  
Strength Rate Packing Style
3.125mg 9.00 10s tablets
6.25mg 17.93 10s tablets
12.5mg 30.00 10s tablets
25mg 52.00 10s tablets

List of Related Indications:
  • Hypertension

List Of Drugs:
  • Carvedilol ( ** ) @ - Alpha/Beta adrenergic blocker

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Interaction with Food

Pregnancy and lactation

   

Drug Interaction:

Alpha/Beta - Adrenergic blocking agents include-

Labetalol, Carvedilol,

 Interacting drugs- summary

Cravediol +

 Antidiabetic agents

agents with beta-blocking properties may enhance the blood sugar-reducing effect of insulin and oral hypoglycaemics. Patients taking insulin or oral hypoglycaemics, regular monitoring of blood glucose is recommended.

Calcium blockers

incr isolated instances of conduction disturbance (rarely with hemodynamic compromise) have been observed when cravediol is coadministered with diltiazem. If carvediol is to be administered with verapramil or diltiazem type, it is recommended that ECG and blood pressure is monitored

Clonidine

 concomittant administration of clonidine with agents with beta blocking properties may potentiate blood pressure and heart rate lowering effects. Discontinue beta blocking agent first. Clonidine therapy can then be discontinued several days later by gradually decreasing the dosage.

Digoxin

digoxin concentrations are increased by about 15% during concurrent use. Increased monitoring of digoxin is recommended, when initiating, adjusting or discontinuing carvediol.

+ Carvediol

 Cimetidine

 cimetidine increased carvediol AUC by about 30% but caused no changes in C max

Rifampin

rifampin reduced plasma concentration of carvediiol by about 70%.